ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 551,90
0,54%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Tempest Therpeutics Inc (TPST)

  7. Tempest Therpeutics Inc (TPST) Actualités

TPST Tempest Therpeutics Inc

2,9001
-0,1299 (-4,29%)
15 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Tempest Therpeutics Inc TPST NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,1299 -4,29% 2,9001 06:00:03
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,10 2,84 3,10 2,90 3,03
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
15/6/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:41EDGAR2Form 8-K - Current report
07/6/202410:30GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
21/5/202414:00GLOBETempest to Participate in Upcoming Investor Conferences
13/5/202422:54EDGAR2Form SC 13D/A - General statement of acquisition of..
09/5/202422:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:29GLOBETempest Reports First Quarter 2024 Financial Results and..
09/5/202422:25EDGAR2Form 8-K - Current report
26/4/202422:05GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
09/4/202414:00GLOBETempest Reports New Preclinical Data for TPST-1120 in RCC at..
04/4/202414:00GLOBETempest Announces Publication of Positive Data from Phase 1..
19/3/202421:25GLOBETempest Reports Year End 2023 Financial Results and Provides..
12/3/202413:00GLOBETempest Presents New Data at the SITC 2024 Spring Scientific..
05/3/202422:30GLOBETempest Announces Upcoming Presentation of Preclinical Data..
26/2/202414:00GLOBETempest to Present at the 44th Annual TD Cowen Healthcare..
15/2/202400:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202420:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202423:41EDGAR2Form SC 13D/A - General statement of acquisition of..
02/2/202422:30GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
05/1/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:05GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
01/12/202322:15GLOBETempest Reports Inducement Grant Under Nasdaq Listing Rule..
20/11/202314:00GLOBETempest to Present at the 35th Annual Piper Sandler..
17/11/202322:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202322:45EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202322:44EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202322:44EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202322:43EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/11/202322:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202323:28EDGAR2Form SC 13D/A - General statement of acquisition of..
08/11/202323:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202323:18EDGAR2Form 8-K - Current report
08/11/202323:17GLOBETempest Reports Third Quarter 2023 Financial Results and..
02/11/202321:16EDGAR2Form 144 - Report of proposed sale of securities
30/10/202311:06EDGAR2Form 8-K - Current report
13/10/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/10/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202312:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/10/202314:29EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
11/10/202314:13EDGAR2Form 8-K - Current report
11/10/202314:01GLOBETempest Adopts Limited Duration Stockholder Rights Plan
11/10/202314:00GLOBETempest Releases New Data Demonstrating Superiority of..
10/10/202322:05GLOBETempest to Report New and Updated Data from Global..
19/9/202314:00GLOBETempest Announces Expanded Role for Sam Whiting, M.D.,..
08/9/202322:16EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
TPST
Tempest Therpeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés